When big pharma is price-gouging, they are going to lose subsidies.
Ron Wyden: “When big pharma is price-gouging, they are going to lose subsidies.”
On the recordApril 14, 2021
Source
congress.govEditor's note · Context
Proposing consequences for pharmaceutical companies that engage in price gouging.
Share
More from Ron Wyden
Oct 15, 2026
The Department’s recent decision in August 2026 to quietly strip explicit prohibitions against political interference from its Scientific Integrity Policy is yet another attempt by the Trump administration to undermine scientific facts and…
Oct 8, 2026
This interpretation is wildly inconsistent with the longstanding treatment of other provisions that use identical or near-identical language.
Oct 8, 2026
This is another desperate attempt by a failed president to escape Americans’ revulsion with his failed agenda, amounting to one tank of Trump-inflated gas.





